📢 Discounted Advance Rates for DIA's Real-World Evidence Conference expire tomorrow, September 26!
· Gain a comprehensive understanding of the latest advancements and regulatory updates in RWE from leading experts in the field
· Engage with industry leaders, regulatory authorities, and peers to discuss innovative strategies and practical applications in RWE. Hear from speakers from the FDA, Eli Lilly and Company, Aetion, Flatiron Health, AstraZeneca, Amgen, Friends of Cancer Research, GSK, Sanofi and more!
· Explore diverse use cases and methodological insights across early development, late-phase, and post-marketing scenarios to enhance your knowledge and practice
· Discover cutting-edge technologies and operational strategies that are shaping the future of RWE generation
· Examine the intersection of AI and RWE, and discuss the implications for policy and regulatory frameworks
See you in Philadelphia!
David Martin, John Concato, Diane Gubernot, DrPH, MPH, Jaclyn Bosco, Dr. Rachele Hendricks-Sturrup, Camille Jackson, Charles Lee, Sarah K. Martin, MS, PhD, Brittany Avin McKelvey, Keri Monda